Reports for ABBVIE CORPORATION

Company Name

ABBVIE CORPORATION

Totals

Shortage reports

111
Actual shortage: 3 (3%)
Anticipated shortage: 0 (0%)
Avoided shortage: 5 (5%)
Resolved: 103 (93%)

Discontinuation Reports

9
To be discontinued: 0 (0%)
Discontinued: 8 (89%)
Reversed: 1 (11%)

Late reports

3 (3%)

Overdue reports

2 (67%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALPHAGAN P 0.15% SOLUTION Resolved 2023-08-14 2023-12-14 201801
ALPHAGAN P 0.15% SOLUTION Resolved 2023-08-14 2023-11-28 201805
FML 0.1% DROPS Resolved 2019-08-14 2019-09-21 91579
FML 0.1% DROPS Resolved 2019-10-24 2019-11-08 97085
FML 0.1% DROPS Resolved 2020-02-10 2020-03-05 105623
FML 0.1% DROPS Resolved 2020-03-25 2020-04-22 109342
FML 0.1% SUSPENSION DROPS Resolved 2022-11-29 2023-09-29 176192
RESTASIS 0.05% EMULSION Resolved 2023-01-10 2023-01-27 180339
RESTASIS MULTIDOSE 0.05% EMULSION Resolved 2019-02-01 2020-03-19 74356
RESTASIS MULTIDOSE 0.05% EMULSION Resolved 2023-02-10 2023-03-02 184397
RESTASIS MULTIDOSE 0.05% EMULSION Resolved 2023-06-08 2023-07-20 194083

Showing 101 to 111 of 111

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NORVIR 80MG SOLUTION Discontinued 2019-02-20 2019-04-01 76354
MODERIBA 600MG TABLET Discontinued 2017-11-20 2018-05-07 29835
LUPRON 5MG SOLUTION Discontinued 2022-01-31 2022-08-17 153896
HOLKIRA PAK 50MG 12.5MG 250MG 75MG KIT TABLET Discontinued 2017-11-30 2018-08-30 31302
HUMIRA 40MG SOLUTION Discontinued 2020-06-29 2020-11-19 119141
MODERIBA 400MG TABLET Discontinued 2017-11-30 2018-08-30 31316
MODERIBA 200MG TABLET Discontinued 2017-11-21 2018-08-30 29907
TECHNIVIE 12.5MG 75MG 50MG TABLET Discontinued 2017-11-20 2018-05-07 29839
ALPHAGAN 0.2% LIQUID Reversed 2021-12-09 2023-12-14 150885

Showing 1 to 9 of 9